For a man facing a prostate biopsy, an MRI scan can give doctors a clearer idea of where to look for cancer before they collect tissue samples. That approach has become much more common at U.S.

A twist on magnetic resonance imaging that does not require gadolinium contrast appears to be as effective as standard imaging at detecting prostate cancers, according to a new study in JAMA. Experts ...

A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

A real-world clinical validation of a commercial AI system for prostate MRI found high sensitivity for clinically significant ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...

Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer. Detection of clinically insignificant ISUP grade group 1 prostate ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

HT Health Talk: Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it?

Researchers in Sweden say a tool, known as Stockholm3, finds 90 per cent of 'clinically significant' prostate cancers, compared with 74 per cent uncovered by the standard prostate-specific antigen ...